Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites-Reference-Cited by-同舟云学术

Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites

Published:1996-10 Issue:4 Volume:25 Page:481-490
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Gentilini Paolo,Villa Giorgio La,Marra Fabio,Carloni Vinicio,Melani Lorenzo,Foschi Marco,Cotrozzi Giorgio,Quartini Mariano,Chibbaro Guido,Tommasi Alberto Candidi,Bernareggi Alberto,Simoni Antonella,Buzzeli Giampiero,Laffi Giacomo

Publisher

Elsevier BV

Subject

Hepatology

Reference38 articles.

1. Refractory ascites in cirrhosis: mechanism and treatment;Arroyo;Gastroenterol Int,1989

2. Refractory ascites;Gentilini;Gastroenterol Int,1994

3. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients;Gatta;Hepatology,1991

4. Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance;Pinzani;Gastroenterology,1987

5. Furosemide kinetics in patients with hepatic cirrhosis with ascites;Fuller;Clin Pharmacol Ther,1981

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Critical Review of Clinical Pharmacokinetics of Torasemide;Therapeutic Drug Monitoring;2024-01-01

2. Pharmacokinetics and Pharmacodynamics of Drugs in Liver Disease;Peri-operative Anesthetic Management in Liver Transplantation;2023

3. Hepatic impairment as a risk factor of adverse drug reactions;Consilium Medicum;2021-12-15

4. Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations;Expert Opinion on Drug Metabolism & Toxicology;2019-12-11

5. Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension;Hepatology;2019-02-09